Preethi Sundaram - Jun 10, 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Strategy Officer
Signature
/s/ Preethi Sundaram
Stock symbol
CPRX
Transactions as of
Jun 10, 2025
Transactions value $
-$103,649
Form type
4
Date filed
6/12/2025, 05:00 PM
Previous filing
Feb 19, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sundaram Preethi Chief Strategy Officer 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES /s/ Preethi Sundaram 2025-06-12 0001872422

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common Stock, par value $0.001 per share Sale -$61.4K -2.32K -5.16% $26.41 42.7K Jun 10, 2025 Direct F1, F2
transaction CPRX Common Stock, par value $0.001 per share Sale -$42.3K -1.6K -3.75% $26.42 41.1K Jun 11, 2025 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in a range from $26.39 to $26.49 per share.
F3 Represents a weighted average price for the shares sold. Shares were sold in a range from $26.39 to $26.48 per share.